Star Therapeutics Revenue
Biotechnology Research • 
South San Francisco, California, United States • 51-100 Employees
Star Therapeutics revenue & valuation
| Annual revenue | $3,100,000 |
| Revenue per employee | $59,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $10,000,000 |
| Total funding | $215,000,000 |
Key Contacts at Star Therapeutics
Adam Rosenthal
Ceo And Founder
Van Leang
Executive Director, Cmc Technical Operations
Robert Benda
Executive Director, Qa
Paul Sims
Associate Director
Jarrod Tremayne
Executive Director, Head Of Project Management
Almudena Tercero
Senior Director Clinical Operations
Laura Guido
Executive Director, Head Of Medical Affairs
Geoff Horner
Director Of Analytical Development And Quality Control
Eileen Rose
Director, Research
Chuka Didigu
Medical Director
Company overview
| Headquarters | South San Francisco, California, United States |
| Phone number | +18887421338 |
| Website | |
| NAICS | 541714 |
| Employees | 51-100 |
| Socials |
Star Therapeutics Email Formats
Star Therapeutics uses 5 email formats. The most common is {first initial} (e.g., j@star-therapeutics.com), used 48.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@star-therapeutics.com | 48.7% |
{first initial}{last name} | jdoe@star-therapeutics.com | 25.6% |
{first name} | john@star-therapeutics.com | 10.3% |
{first name}{last name} | johndoe@star-therapeutics.com | 10.3% |
{first initial}{last name}{last name} | jdoedoe@star-therapeutics.com | 5.1% |
About Star Therapeutics
Star Therapeutics is a clinical stage biotechnology company discovering and developing best-in-class antibodies to create life-changing therapies for patients, initially addressing unmet needs in hematology and immunology. The company applies its expertise in antibody innovation to interrogate areas of biology that have been overlooked and have the potential for addressing multiple diseases with a single therapy. Our lead program, VGA039, has the potential to be a universal hemostatic therapy that can treat numerous bleeding disorders, starting with von Willebrand disease (VWD). As a subcutaneously self-administered antibody therapy with convenient dosing, VGA039 has the potential to significantly reduce the treatment burden for patients.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Star Therapeutics has 26 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore Star Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Star Therapeutics Tech Stack
Discover the technologies and tools that power Star Therapeutics's digital infrastructure, from frameworks to analytics platforms.
WordPress plugins
Video players
JavaScript libraries
Page builders
JavaScript libraries
Font scripts
WordPress themes
JavaScript libraries
Programming languages
Blogs
Analytics
UI frameworks
Sweden
Netherlands
Bangladesh
CzechiaFrequently asked questions
4.8
40,000 users
